“In Malaysia, there will be no political pressure and we will not use the emergency-use pathway.
Malaysia has ordered the Pfizer-Biontech vaccine and an alternative from COVAX that would roughly cover 30 per cent of the population, which will be delivered in batches next year.
However, no country has yet given full regulatory approval to any Covid-19 vaccine candidate so far.
This has led to some sections here in Malaysia and elsewhere to express concern over the potential dangers and side effects that may have been overlooked in the rush to produce a reliable vaccine against the world-stopping Covid-19 pandemic.
The Health Ministry has repeatedly assured Malaysians that any and all vaccines to be used here will be fully studied and evaluated to ensure they are safe to use.
Malaysia is grappling with a third wave of Covid-19 infections that has pushed the country’s total cases to over 80,000.
For any query with respect to this article or any other content requirement, please contact Editor at email@example.com
Copyright 2017 Malay Mail Online